By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Supermicro's $39 billion backlog and AI demand potential are genuine, but execution risks, dilution, and regulatory issues are significant concerns. The key metric is converting the backlog into cash flow in Q4 without further dilution.
Risk: Failure to convert the backlog into cash flow in Q4 without further dilution
Opportunity: Potential 25-30% re-rating if Q4 guidance holds and gross margins don't compress
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
One of the greatest challenges for artificial intelligence stocks is that it’s an expensive business. Hyperscalers like Amazon (AMZN), Alphabet (GOOG) (GOOGL), Microsoft (MSFT), and Meta Platforms (META) are spending $700 billion this year on AI infrastructure to create the computing capacity needed to meet an ever-increasing demand.
That strain is also felt by companies like Super Micro Computer (SMCI), which recently announced it was seeking $7 billion in financing to support an AI server backlog of $39 billion. The announcement drew concern among both analysts and investors, and the stock is down sharply.
However, we’ve seen this kind of selloff before in the AI space—each of the aforementioned hyperscalers dipped in the first quarter on fears that their capex spending was too aggressive. And all four showed dramatic improvement in Q2.
Can Supermicro, as its often called, follow the same script?
About Super Micro Computer Stock
Super Micro Computer, which is based in San Jose, California, plays an important role in the AI space. The company creates custom server motherboards, liquid-cooling racks, and other AI infrastructure required to house bundled semiconductors that are working together to complete AI tasks. Its server solutions are used in data centers as well as for high-performance computing, high-end workstations, networks, and standalone server installations.
The company’s shares have been a disappointment, down 25% in the last year, while the S&P 500 ($SPX) rose 27%, and the S&P 1500 Information Technology sector is up more than 55%.
SMCI stock is currently trading at a low forward price-to-earnings ratio of 11.8, which is less than half of its three-year mean of 22.9, indicating that the shares are cheap right now. But the stock performance makes Supermicro a contrarian pick right now for many investors.
The most recent headwind is the company’s announcement that it was seeking up to $7 billion in funding to pay for a backlog of $39 billion in orders from more than 20 companies. The proposed offerings would include $5 billion in stock underwritten by investment banks, including $1.25 billion in new common shares and $3.75 billion from depository shares. In addition, the company is proposing a $2 billion at-the-market offering, meaning the company would sell up to that level over time.
The underwritten offer will result in 45.45 million shares of common stock at a public offering price of $27.50 per share and 75 million depositary shares, each representing a 1/20th interest in a share of newly issued 7% series A mandatory convertible preferred stock at a public offering price of $50 per share.
But the dilution in shares isn’t being received well by investors. SMCI stock, which was trading at $44.90 before the company’s announcement, fell 30.6% in just five days as the company rolled out the details of the offering in announcements on June 9 and June 11.
Supermicro Beats on Earnings
Supermicro reported solid earnings for its fiscal third quarter (ending March 31). Revenue of $10.2 billion was up from $4.6 billion a year ago, and net income was $483 million versus $109 million in the fiscal third quarter of 2025. Earnings per share were $0.72, which soundly beat analysts’ expectations for EPS of $0.55.
Notably, SCMI’s revenue dropped 19% on a sequential basis, which management attributed to component shortages and customer site readiness delays.
“Despite the industry-wide shortage of key components, including CPU, GPU, and memory, our business continues to grow and expand. Indeed, our backlog is now at another record high,” CEO Charles Liang said.
The company is also expanding its production by ramping up facilities in Taiwan and Malaysia and plans to build a new facility in Silicon Valley that will bring Supermicro’s footprint in the San Francisco to nearly 4 million square feet.
Supermicro issued fourth-quarter and full-year guidance that calls for net sales of $11 billion to $12.5 billion in Q4 and $38.9 billion and $40.4 billion for fiscal 2026.
Supermicro Addresses Legal Issues
The company also distanced itself in the earnings call from co-founder and board member Yih-Shyan “Wally” Liaw, sales manager Ruei-Tsang “Steven” Chang, and contractor Ting-Wei “Willy” Sun, who were indicted by the U.S. government in March on charges that they allegedly attempted to divert $2.5 billion in Nvidia (NVDA)-powered AI servers to China, which would be a violation of U.S. export controls.
Liang said all three were terminated, and the company is cooperating with the Justice Department. “The alleged actions of a few individuals do not define us,” he said.
Liang said the company is not under indictment and is not a target of the investigation, and he believes that the company will not need to restate its earnings. The company also retained an outside law firm and a forensic firm to conduct an independent investigation.
“We will take to heart the results of the independent investigation and look at that as an opportunity to grow and strengthen,” he said.
What Do Analysts Think of SMCI Stock?
Considering the legal issues and the upcoming dilution of shares, analysts are understandably reserved. Twenty analysts who cover the stock have a consensus “Hold” rating on the stock, down from “Moderate Buy” three months ago. Only five have “Buy” ratings and three have “Sell” ratings.
However, the mean price target of $38.87 represents a potential upside of nearly 25%, which plays into the idea that SMCI stock is somewhat undervalued right now.
As said before, buying Supermicro's stock today is a contrarian play. While hyperscalers like Alphabet are making similar moves to raise money—the owner of Google is selling $80 billion in shares to pay for its AI ambitions—Supermicro comes with a lot more baggage. The company was also delisted from the Nasdaq in 2018 for not filing financial reports in a timely manner and then was fined in 2020 by the Securities and Exchange Commission for accounting violations.
So, it’s no solid bet that Supermicro will be able to follow the Alphabet playbook. A measured stance by investors—and a skeptical eye—is more appropriate.
On the date of publication, Patrick Sanders had a position in: NVDA. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Four leading AI models discuss this article
"The company's sequential revenue decline despite record backlog indicates structural execution failures that share dilution alone cannot fix."
Supermicro is currently caught in a liquidity trap masquerading as a growth story. While the 11.8x forward P/E suggests value, the market is correctly pricing in a 'distrust discount.' The $7 billion financing isn't just growth capital; it's a desperate scramble to manage working capital for a $39 billion backlog that is clearly straining their balance sheet. The sequential revenue drop of 19% is the real red flag, suggesting that despite massive AI demand, Supermicro is struggling with execution and component bottlenecks. Until they prove they can turn that massive backlog into actual cash flow without persistent dilution or further regulatory scrutiny, the stock remains a value trap.
If Supermicro successfully navigates its supply chain bottlenecks and proves its liquid-cooling technology is the industry standard for high-density AI clusters, the current valuation will look like an generational entry point once the dilution is absorbed.
"SMCI's 11.8x forward P/E reflects panic, not fundamentals—but the company must prove Q4 guidance and margin stability amid dilution and legal overhang before the 25% analyst upside target is credible."
The article frames SMCI's 30% drop as justified skepticism, but conflates two separate problems. Yes, $7B in dilutive financing is real friction—45.45M common shares at $27.50 plus convertibles will suppress near-term EPS. But the $39B backlog and 122% YoY revenue growth (fiscal Q3) are genuine. The legal issues sting reputationally, yet the company isn't indicted and three individuals were terminated. The real tension: SMCI trades 11.8x forward P/E versus 22.9x historical mean. If Q4 guidance ($11-12.5B) holds and gross margins don't compress from dilution-driven production chaos, this is a 25-30% re-rating opportunity. The article's comparison to Alphabet's $80B raise is misleading—Alphabet has fortress balance sheet and zero legal baggage.
The article underplays execution risk: ramping Taiwan/Malaysia facilities while managing export-control scrutiny and integrating a forensic investigation is operationally brutal. If component shortages persist or customer 'site readiness delays' extend, that $39B backlog converts to revenue miss, and the dilution becomes permanently accretive-negative.
"Dilution at these levels plus export-control and governance baggage outweigh the apparent valuation discount given execution uncertainties."
SMCI's $7B capital raise via heavy common and preferred dilution at depressed prices signals acute cash strain to fund a $39B backlog amid component shortages and site delays. Sequential revenue decline of 19% plus lingering export-control indictments involving former executives introduce execution and compliance risks that hyperscaler capex analogies overlook. Forward P/E of 11.8 prices in some skepticism, yet history of Nasdaq delisting and accounting fines suggests governance overhang could cap re-rating even if Q4 guidance of $11-12.5B is met.
The $39B backlog, if converted without further slippage, could generate EPS growth that more than offsets dilution and push the multiple back toward historical averages, mirroring how AMZN and MSFT recovered from Q1 capex scares.
"Backlog-driven revenue growth and scalable capacity expansion can compensate for dilution, potentially driving a mid-term re-rating in SMCI if execution remains solid and the legal issues stay contained."
SMCI looks like a high-beta AI infrastructure play: a record backlog, ongoing capacity expansion, and a financing plan that could translate demand into revenue if execution and supply chains cooperate. The stock's ~30% drop on dilution fears may be overdone, given Q3 revenue of $10.2B and backlog at new highs. Still, dilution and the legal overhang are real headwinds, and the mix of equity plus ATM could cap upside unless backlog-to-revenue conversion proves durable. If independent investigations clear the company and hyperscalers maintain capex, SMCI could re-rate as an AI infrastructure supplier with improving scale and potential margins.
The backlog could be unreliable or front-loaded, and the $7B financing might imply cash burn or weak current cash flow; any delay or cancellation could trigger sharper dilution and a further decline in SMCI's multiple.
"SMCI's backlog is increasingly vulnerable to customer churn as hyperscalers prioritize reliable, non-dilutive suppliers like Dell and HPE."
Claude, you’re glossing over the 'site readiness' excuse. Hyperscalers like NVDA aren't just waiting on SMCI; they are diversifying to Dell and HPE to mitigate supply chain volatility. SMCI’s $39B backlog is a vanity metric if they lack the working capital to secure priority components from TSMC or SK Hynix. If they are diluting shareholders just to pay suppliers for inventory that isn't shipping, this isn't a re-rating play—it's a liquidity-driven death spiral.
"SMCI's backlog credibility hinges on Q4 revenue realization and margin stability, not on whether dilution prevents supplier payment."
Gemini's 'death spiral' framing assumes SMCI can't service the backlog without dilution—but the $7B raise explicitly funds capacity expansion and working capital, not supplier payments for stranded inventory. The real test: Q4 revenue guidance ($11–12.5B) either validates backlog conversion or doesn't. Diversification to Dell/HPE is real competitive pressure, yet SMCI's liquid-cooling tech remains differentiated for hyperscale AI. The backlog isn't vanity if gross margins hold; it's vanity only if revenue misses.
"Site delays turn the $7B raise into recurring burn, not a fix."
Gemini overlooks how customer site readiness delays directly amplify SMCI's working capital strain beyond simple supplier payments. Even post-raise, if hyperscalers defer installations into FY2026, the $39B backlog risks aging into inventory write-downs while fixed dilution hits EPS immediately. This timeline mismatch could force further ATM draws before Q4 proves conversion.
"The real test is cash conversion—not just backlog magnitude."
Grok’s focus on backlog aging and governance risk is valid, but it underestimates timing risk. Even with the $7B raise, revenue realization can skew to later quarters if site readiness drags or customer deploy windows slip. If a larger chunk of the backlog remains unrecognized into FY2026, the stock stays capped despite a credible Q4 guide. The real test is cash conversion—not just backlog magnitude.
Supermicro's $39 billion backlog and AI demand potential are genuine, but execution risks, dilution, and regulatory issues are significant concerns. The key metric is converting the backlog into cash flow in Q4 without further dilution.
Potential 25-30% re-rating if Q4 guidance holds and gross margins don't compress
Failure to convert the backlog into cash flow in Q4 without further dilution